Aesthetic Injectable Market Size To Reach $24.13 Billion By 2030

Aesthetic Injectable Market Growth & Trends

The global aesthetic injectable market size is expected to reach USD 24.13 billion by 2030, registering a CAGR of 12.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The industry is experiencing notable growth driven by several factors. These include increasing consumer awareness about minimally invasive cosmetic procedures, advancements in injectable technologies, and rising demand for non-surgical aesthetic enhancements.

Technological and research progress has led to the development of inventive injectable formulations, expanding the market's offerings to include various products addressing precise concerns like fine lines, wrinkles, volume loss, and skin texture. For instance, according to the National Center for Biotechnology and Information (NCBI) in January 2024, the injectable Sculptra Poly-L-Lactic Acid (PLLA-SCA) treatments were well received and notably diminished the severity of moderate to severe wrinkles and cheek lines while enhancing skin quality. Their effectiveness remained consistent throughout the 12-month study, with subjects reporting high satisfaction, achieving a natural appearance, and expressing eagerness for further treatments.

Additionally, shifting beauty standards and a growing aging population contribute to market expansion. Moreover, the availability of a wide range of injectable products, coupled with innovative marketing strategies by key players, further stimulates market growth. Furthermore, favorable regulatory frameworks and an expanding network of aesthetic clinics and medical spas are fostering the uptake of aesthetic injectables worldwide.

 Request a free sample copy or view report summary: Aesthetic Injectable Market Report

Aesthetic Injectable Market Report Highlights

• Based on the product, the botulinum toxin (Botox) segment accounted for the largest revenue share of 45.8% in 2023 as it is used temporarily to reduce the appearance of facial wrinkles and fine lines

• The hyaluronic acid (HA) segment is expected to grow at the fastest CAGR of 12.7% during the forecast period as it provides the advantage of enhancing skin hydration, volume, and elasticity, resulting in a smoother and more youthful appearance

• Based on the end-use, the medical spas segment accounted for the largest revenue share of 46.9% in 2023 and is expected to grow at the fastest CAGR of 12.3% during the forecast period. Medical spas contribute to the growth of the aesthetic injectables market by offering a range of cosmetic procedures, including injectable treatments, in a relaxing and luxurious environment

• Based on the application, the facial line correction segment accounted for the largest revenue share of 33.4% in 2023 and is expected to grow at the fastest CAGR of 12.5% during the forecast period, as it addresses various concerns such as fine lines, wrinkles, and volume loss for facial rejuvenation

• In 2023, North America dominated with a share of 39.3% due to the constant demand for cosmetic enhancement products and Asia Pacific is expected to grow at the fastest CAGR of 15.8% during the forecast period as this region is a hub for technological innovation, with continuous advancements in aesthetic injectables and techniques

Aesthetic Injectable Market Segmentation

Grand View Research has segmented the global aesthetic injectable market based on product, end-use, application and region:

Aesthetic Injectable Product Outlook (Revenue, USD Million, 2018 - 2030)

• Hyaluronic Acid (HA)

• Botulinum Toxin (Botox)

• Aquatic Light Injections

• Others

Aesthetic Injectable End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Medical Spas

• Dermatology Clinics

• Hospitals

Aesthetic Injectable Application Outlook (Revenue, USD Million, 2018 - 2030)

• Facial Line Correction

• Lip Augmentation

• Face Lift

• Acne Scar Treatment

• Lipoatrophy Treatment

• Others

Aesthetic Injectable Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List Of Key Players in the Aesthetic Injectable Market

• Ipsen Pharma

• AbbVie, Inc.

• Merz GmbH and Co. KGaA

• Galderma

• Prollenium Medical Technologies, Inc.

• Suneva Medical, Inc.

• Sinclair Pharma

• Medytox, Inc.

• Revance Therapeutics, Inc.